Terrified of a no-deal Brexit? 4 FTSE 100 stocks I think can help you protect yourself

Royston Wild discusses a cluster of FTSE 100 (INDEXFTSE: UKX) that could help you ride out the worst of all Brexit scenarios.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

As the great Brexit problem swells and swells and threatens to block out the sun, it’s understandable many of us long simply to sit in a dark cupboard until the protracted saga is truly over and done with.

It’s an issue that’s particularly stressful for investors with a high exposure to the UK economy and who are desperate for government to strike a deal with our European Union partners. Theresa May’s latest failure to get her Withdrawal Agreement passed by the Commons last night led European Commission president Donald Tusk to proclaim that the possibility of a no-deal Brexit has “significantly increased.”

We’re just a short time away from the planned EU departure date of March 29 and, rather shockingly, the prospect of a potentially-ruinous Brexit remains very much in play. With this in mind, it’s time to shop smart and I believe that buying these FTSE 100 stocks is a great way to help protect yourself.

Passive income stocks: our picks

Do you like the idea of dividend income?

The prospect of investing in a company just once, then sitting back and watching as it potentially pays a dividend out over and over?

If you’re excited by the thought of regular passive income payments, as well as the potential for significant growth on your initial investment…

Then we think you’ll want to see this report inside Motley Fool Share Advisor — ‘5 Essential Stocks For Passive Income Seekers’.

What’s more, today we’re giving away one of these stock picks, absolutely free!

Get your free passive income stock pick

Safe haven

Healthcare is one of the great lifeboats in troubled times and for this reason AstraZeneca is a great pick, in my opinion. Of course this pharma giant’s products are in high demand in the UK, but this market represents just a fraction of its total global profits. Irrespective of any geographical split though, it’s not as if we can expect sales of AstraZeneca’s medicines to fall off a cliff, either, even in the event of an economically-destructive Brexit, given the essential role they have in all of our lives.

Extra security

I’d extend the same courtesy to Smith & Nephew, too. It could be argued that this company’s product suite of artificial joints and limbs are not as indispensable for the broader population as most of the medicines that AstraZeneca churns out. Like its FTSE 100 colleague though, Smith & Nephew can be confident that its pan-global presence can take the sting out of any sales slump in its home market.

Indeed, I’ve lauded the blue-chip’s rising might in emerging markets, like China in particular, and reckon these territories should power profits to the stars in the future.

The gold standard

The ultimate safe-haven asset in troubled economic and political times, getting exposure to gold could also prove a good idea as the UK contorts under the pressure of Brexit.

Latest data from retailer The Pure Gold Company, detailing a 119% surge in physical bars and coins (versus the 2019 average) over the past 24 hours, illustrates this point perfectly. And investor interest is only likely to perk up as the country moves closer to the no-deal trapdoor.

A perfect way to play this theme? Buying dedicated gold and silver Fresnillo, of course.

Great protection

My final selection is National Grid. This Footsie firm has some exposure to the US but I don’t think it needs to worry about the possibility of tougher trading conditions in its domestic marketplace.

It’s charged with keeping the lights on whatever economic condition the country is in, and this protects it from the sort of earnings turbulence that many other UK-focussed companies face in the near term and beyond. This means that efforts to build its asset base on these shores should still create plenty of upside, regardless of how Brexit turns out.

Amazing Nerd Stock smashes FTSE with 1,346% gains

What makes this company so extraordinary?

It has a cult-like following of nerdy fans who tend to spend lots of money…

potentially handing investors market-beating gains in any economy.

Though past performance does not guarantee future results, last year, this amazing company saw:

  • Double-digit revenue growth - to a total £470,800,000
  • Profits explode 46%
  • Insiders buying a monster £492,000 of shares

…Setting investors up for - what could be - another decade of spectacular returns.

Want to consider joining them?

Then grab this special report: ‘One Top Growth Stock from The Motley Fool’ which includes both the risks and opportunities.

Secure your FREE copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended AstraZeneca and Fresnillo. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Prediction: in 1 year, the IAG share price could reach as high as…

The IAG share price has almost doubled in the last 12 months, but can this momentum continue in 2025? Zaven…

Read more »

Investing Articles

Prediction: in 12 months, here’s where the Glencore share price could be…

The performance of Glencore’s share price has been lacklustre, to say the least. But could all that change over the…

Read more »

Investing Articles

See how much an investor needs in their ISA to earn a £499 monthly second income

Harvey Jones crunches the numbers to show how it's possible to build a long-term second income by investing in a…

Read more »

Investing Articles

I’m considering buying more of this struggling FTSE 100 stock

This FTSE 100 stock hasn't exactly set our writer's portfolio on fire during the time he's owned it. But Paul…

Read more »

a couple embrace in front of their new home
Investing Articles

Prediction: in 1 year, the Taylor Wimpey share price could reach…

Can Britain’s reformed planning scheme send the Taylor Wimpey share price into overdrive? Here’s what the latest analyst forecasts predict.

Read more »

Investing Articles

Forecast: in 12 months, the Aviva share price could be…

Aviva is preparing to swallow its £3.7bn acquisition of Direct Line, which is expected to significantly improve profitability. Is now…

Read more »

Investing Articles

Forecast: in 1 year, the Shell share price could be…

The Shell share price hasn’t moved much in the last 12 months, but analyst forecasts predict that could change significantly…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Forecast earnings growth of 17% a year but down 12%, is now the time for me to buy this heavyweight FTSE stock?

This FTSE medical technology stock has strong earnings growth projections, posted impressive 2024 results, and looks very undervalued to me.

Read more »